Inferring the disruption of rabies circulation in vampire bat populations using a betaherpesvirus-vectored transmissible vaccine

Griffiths, M. E. , Meza, D. K., Haydon, D. T. and Streicker, D. G. (2023) Inferring the disruption of rabies circulation in vampire bat populations using a betaherpesvirus-vectored transmissible vaccine. Proceedings of the National Academy of Sciences of the United States of America, 120(11), e2216667120. (doi: 10.1073/pnas.2216667120) (PMID:36877838) (PMCID:PMC10089182)

[img] Text
290547.pdf - Published Version
Available under License Creative Commons Attribution.

1MB
[img] Text
290547Suppl.pdf - Supplemental Material

1MB

Abstract

Transmissible vaccines are an emerging biotechnology that hold prospects to eliminate pathogens from wildlife populations. Such vaccines would genetically modify naturally occurring, nonpathogenic viruses (“viral vectors”) to express pathogen antigens while retaining their capacity to transmit. The epidemiology of candidate viral vectors within the target wildlife population has been notoriously challenging to resolve but underpins the selection of effective vectors prior to major investments in vaccine development. Here, we used spatiotemporally replicated deep sequencing to parameterize competing epidemiological mechanistic models of Desmodus rotundus betaherpesvirus (DrBHV), a proposed vector for a transmissible vaccine targeting vampire bat-transmitted rabies. Using 36 strain- and location-specific time series of prevalence collected over 6 y, we found that lifelong infections with cycles of latency and reactivation, combined with a high R0 (6.9; CI: 4.39 to 7.85), are necessary to explain patterns of DrBHV infection observed in wild bats. These epidemiological properties suggest that DrBHV may be suited to vector a lifelong, self-boosting, and transmissible vaccine. Simulations showed that inoculating a single bat with a DrBHV-vectored rabies vaccine could immunize >80% of a bat population, reducing the size, frequency, and duration of rabies outbreaks by 50 to 95%. Gradual loss of infectious vaccine from vaccinated individuals is expected but can be countered by inoculating larger but practically achievable proportions of bat populations. Parameterizing epidemiological models using accessible genomic data brings transmissible vaccines one step closer to implementation.

Item Type:Articles
Additional Information:M.E.G. was supported by a Medical Research Council scholarship via the MRC-CVR PhD programme (MC_UU_12014/12) (https://mrc.ukri.org/). D.K.M. was supported by the Human Frontier Science Program (RGP0013/2018) (https://www.hfsp.org/) and the Mexican National Council for Science and Technology (CONACYT, 334795/472296) (https://www.conacyt.mx/). D.G.S. was supported by a Wellcome Trust Senior Research Fellowship (217221/Z/19/Z) (https://wellcome.org/). This research was funded in part by the Wellcome Trust [Grant number 217221/Z/19/Z].
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Streicker, Professor Daniel and Haydon, Professor Daniel and Meza, Dr Diana and Griffiths, Dr Megan
Authors: Griffiths, M. E., Meza, D. K., Haydon, D. T., and Streicker, D. G.
College/School:College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Proceedings of the National Academy of Sciences of the United States of America
Publisher:National Academy of Sciences
ISSN:0027-8424
ISSN (Online):1091-6490
Published Online:06 March 2023
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in Proceedings of the National Academy of Sciences of the United States of America 120(11): e2216667120
Publisher Policy:Reproduced under a Creative Commons License
Data DOI:10.6084/m9.figshare.20764960.v2

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
172630014Cross-Cutting Programme – Viral Genomics and Bioinformatics (Programme 9)David RobertsonMedical Research Council (MRC)MC_UU_12014/12III - Centre for Virus Research
307106Epidemiology meets biotechnology: preventing viral emergence from batsDaniel StreickerWellcome Trust (WELLCOTR)217221/Z/19/ZInstitute of Biodiversity, Animal Health and Comparative Medicine